Stevanato Group (NYSE:STVN – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.700-0.720 for the period, compared to the consensus estimate of 0.680. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.
Stevanato Group Stock Performance
Shares of STVN traded down €0.69 during trading hours on Tuesday, reaching €19.91. 425,033 shares of the company traded hands, compared to its average volume of 541,206. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €28.00. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.11 and a current ratio of 1.63. The stock has a market cap of $6.03 billion, a P/E ratio of 33.78, a price-to-earnings-growth ratio of 1.77 and a beta of 0.77. The stock’s fifty day moving average is €18.66 and its 200 day moving average is €16.97.
Stevanato Group (NYSE:STVN – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported €0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of €0.15 by €0.01. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.Stevanato Group has set its FY 2026 guidance at 0.700-0.720 EPS. Equities research analysts anticipate that Stevanato Group will post 0.71 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Read Our Latest Research Report on STVN
Insider Activity at Stevanato Group
In other news, Director Karen Flynn sold 1,493 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total transaction of €25,515.37. Following the completion of the sale, the director owned 5,757 shares in the company, valued at €98,387.13. The trade was a 20.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Madhavan Balachandran sold 1,493 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a total value of €25,515.37. Following the transaction, the director directly owned 69,458 shares in the company, valued at €1,187,037.22. This trade represents a 2.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 5,972 shares of company stock worth $102,061.
Institutional Trading of Stevanato Group
Institutional investors have recently bought and sold shares of the business. Royal Bank of Canada boosted its position in shares of Stevanato Group by 10.8% in the 1st quarter. Royal Bank of Canada now owns 437,284 shares of the company’s stock worth $8,930,000 after purchasing an additional 42,731 shares during the last quarter. Sei Investments Co. increased its stake in shares of Stevanato Group by 16.9% in the 2nd quarter. Sei Investments Co. now owns 231,244 shares of the company’s stock valued at $5,649,000 after acquiring an additional 33,419 shares during the last quarter. Raymond James Financial Inc. boosted its stake in Stevanato Group by 21.2% during the 2nd quarter. Raymond James Financial Inc. now owns 567,803 shares of the company’s stock worth $13,871,000 after acquiring an additional 99,328 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in Stevanato Group by 14.2% during the second quarter. Ameriprise Financial Inc. now owns 708,821 shares of the company’s stock valued at $17,316,000 after purchasing an additional 87,942 shares during the period. Finally, Bamco Inc. NY increased its position in shares of Stevanato Group by 2.1% in the 2nd quarter. Bamco Inc. NY now owns 1,888,050 shares of the company’s stock valued at $46,125,000 after buying an additional 39,528 shares in the last quarter.
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Further Reading
- Five stocks we like better than Stevanato Group
- Marriott’s Earnings Drop May Be Missing the Bigger Fee Growth Story
- Apple’s AI Strategy Looks Different—Will It Pay Off?
- The AI Chip Stock Making a Quiet Move Toward Dominance
- Why Walmart and Amazon Could Be the Market’s Most Complementary Mega-Caps
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
